Formulation Featured Articles
-
Nanomedicine Modalities Find Path To Clinic Through Analytics
5/16/2025
Lipid nanoparticles have revolutionized drug delivery, ushering in a new era of nanomedicine. Discover how advanced analytical tools are accelerating next-generation LNP therapeutics.
-
Advancing Cell Therapies With Lipid Nanoparticles
3/24/2025
Cell therapies, using reprogrammed immune cells, offer innovative treatments for diseases. Discover how lipid nanoparticles (LNPs) enhance these therapies by delivering RNA for gene modulation and next-gen treatments.
-
Outsourcing RNA-LNP Production: A Key To Competitive Success
3/6/2025
Manufacturing RNA-containing LNPs demands specialized expertise. Explore some of the challenges of RNA-LNP drug manufacturing and the advantages of outsourcing RNA-LNP formulations.
-
Tune Therapeutics' 2025 Epigenome Editing Outlook
1/10/2025
Chief Scientific Officer Derek Jantz talks about recent key innovations in gene therapy and RNA technology while considering what milestones we might see in 2025.
-
Points To Consider For Assessing Lipid Quality For Lipid Nanoparticle Manufacturing
5/29/2024
Lipid nanoparticles have generated a ton of buzz, but they pose risks that, perhaps, industry and regulators have not taken seriously enough so far.
-
5 Considerations For Buffer Optimization During Biologics Pre-Formulation
5/16/2024
Formulation development is a vital part of the drug development process. Explore key factors to consider in pre-formulation.
-
5 Types Of Formulation Excipients And How They Impact Biologics Stability
5/16/2024
Review how different excipients stabilize biologics in unique ways and are important considerations in the pre-formulation stage.
-
Forum Notebook: Quick Takes From USP's mRNA Virtual Summit
5/1/2024
The United States Pharmacopeia held a forum in February to exchange ideas about analytical methodologies and release testing. Here's a recap of the event.
-
Unpacking The Importance Of Lipid Nanoparticle Production Platforms
4/15/2024
Batch processing platforms for LNPs lack efficiency, appropriate controls, and yield optimization. Continuous manufacturing platforms may address some of those issues.
-
Ophthalmic Drug Delivery
4/11/2024
Explore the challenges to effective delivery of drugs to the eye, intricacies of ophthalmic drug delivery, and advantages of nanoparticles as an enabling technology for ocular drug-delivery systems.